Annovis Bio, Inc. (ANVS)
NYSE: ANVS · IEX Real-Time Price · USD
10.66
-0.68 (-5.96%)
Jul 22, 2024, 10:04 AM EDT - Market open
Annovis Bio Employees
As of December 31, 2023, Annovis Bio had 16 total employees, including 6 full-time and 10 part-time employees. The number of employees increased by 11 or 220.00% compared to the previous year.
Employees
16
Change (1Y)
11
Growth (1Y)
220.00%
Revenue / Employee
n/a
Profits / Employee
-$2,970,880
Market Cap
125.32M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Agenus | 389 |
| Veru Inc. | 189 |
| X4 Pharmaceuticals | 93 |
| Immunic | 77 |
| Athira Pharma | 67 |
| Corvus Pharmaceuticals | 28 |
| Relmada Therapeutics | 20 |
| Nuvectis Pharma | 13 |
ANVS News
- 19 days ago - Annovis stock more than doubled on Tuesday: what happened? - Invezz
- 19 days ago - Annovis Bio's stock rockets 119% after reporting positive data in Parkinson's disease trial - Market Watch
- 26 days ago - Annovis Bio Files Patent for New Composition of Matter for Buntanetap - GlobeNewsWire
- 5 weeks ago - Annovis Bio's Buntanetap Found Safe and Effective in High-Risk Alzheimer's Patients - GlobeNewsWire
- 2 months ago - Annovis Announces New Publication in a Peer-Reviewed Journal - GlobeNewsWire
- 2 months ago - INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors - Business Wire
- 2 months ago - Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors - Business Wire
- 2 months ago - The Law Offices of Frank R. Cruz Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors - Business Wire